Please assess the completion status of the following clinical trial:

Trial Title: Comparison of the Philips MicroDose Tomosynthesis System to 2D Digital Mammography

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: SCREENING
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Patient is female and at least 40 years of age~* No contraindication for routine bilateral mammography~Screening Cohort~* Patient presents for a routine screening mammogram Biopsy Cohort~* Patient is scheduled for a biopsy~* Patient has a screening detected abnormality~Exclusion Criteria:~* Patient is pregnant or believes she may be pregnant; OR,~* Patient is breast feeding; OR~* Patient is unable or unwilling to give informed consent, including consent to reuse data for future research; OR,~* Patient has breast implants; OR~* Patient has previous surgical biopsy; OR~* Patient has previous breast cancer; OR~* Patient presented to screening with clinical symptoms (e.g. palpable lump, nipple discharge, nipple retraction, skin irritation or dimpling)

- Gender: FEMALE
- Minimum Age: 40 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Imaging on experimental tomo device (Type: OTHER): Women will have a bilateral two-view mammogram (a total of four images) with the Philips MicroDose Tomosynthesis system and a bilateral two-view mammogram (a total of four images) with an FFDM system. The order of this will be randomised.~After collecting the cases together with ground truth a readers study will be performed.

Based on this trial design, predict the completion outcome and termination type (if applicable).